WCM
FLGT icon

Wedge Capital Management’s Fulgent Genetics FLGT Stock Holding History

Wedge Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-39,266
Closed -$423K – 529
2020
Q1 		$423K Sell
39,266
-45,955
-54% -$640K 0.01% 359
2019
Q4 		$1.1M Buy
+85,221
New +$1.01M 0.01% 330

Other funds holding FLGT

RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Wedge Capital Management's FLGT Position: Q2 2020 in Review

Wedge Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2020, closing a stake of 39,266 shares — an estimated $423K sold.

Wedge Capital Management first reported a position in FLGT in Q4 2019 and held it in 2 quarters. The position peaked at $1.1M in Q4 2019. 86 funds tracked by Wall St. Rank hold FLGT as of Q2 2020.

  • Wedge Capital Management reported no remaining Fulgent Genetics position as of Q2 2020 after selling out during the quarter.
  • Wedge Capital Management sold 39,266 Fulgent Genetics shares in Q2 2020, an estimated $423K.
  • Wedge Capital Management first reported a position in Fulgent Genetics in Q4 2019 and held it in 2 quarters.
  • Wedge Capital Management's Fulgent Genetics position peaked at $1.1M in Q4 2019.
  • 86 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2020.

Based on Wedge Capital Management's 13F filing for Q2 2020, filed 10 Jul 2020.